SBIR/STTR Research Award
STTR Phase II: Microfluidic CD Biochips for Enzyme-Linked Immunosorbent Assays
Award amount
$0Program and phase
STTR · Phase IAward year
2004Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- BioLOC LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- N3A3FPQCPMM3
- Solicitation number
- NSF 03-535
- Topic code
- BT
Research abstract
The Small Business Technology Transfer (STTR) Phase II project will develop a low-cost and mass-producible lab-on-a-chip platform for molecular and biological analyses. The platform is a microfluidic CD for Enzyme-Linked Immunosorbent Assays (ELISA) that reduces cost, accelerates results, and improves reliability of analyses for food borne contaminants, cancer diagnoses and environmental contamination._x000D__x000D_The CD-ELISA technology platform merges two scientific areas - polymer microfabrication and biotechnology - and can substantially reduce manufacturing costs, improve device performance, and enable the production of low-cost and high-efficiency devices. Moreover, as such a device would be more affordable it will enable point-of-use results for a broader spectrum of molecular and biological testing. _x000D__x000D__x000D_
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
2 SBIR/STTR records share this UEI (2004–2007). Reported award amounts total $500,000. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: National Science Foundation